August 14, 2026 Posted by: Categories: No Comments The European Medicines Agency (EMA) published updated information on several medicines: Nuvaxovid | European Medicines Agency (EMA) Boey | European Medicines Agency (EMA) Lynparza | European Medicines Agency (EMA) RoActemra | European Medicines Agency (EMA) Lutathera | European Medicines Agency (EMA) Ezmekly | European Medicines Agency (EMA)
